Vigabatrin therapy in patient with succinic semialdehyde dehydrogenase deficiency.
Gibson
K M
KM
DeVivo
D C
DC
Jakobs
C
C
D000445:Aldehyde Oxidoreductases; D000614:Aminocaproates; D000927:Anticonvulsants / Q000627:therapeutic use*; D002675:Child, Preschool; D006801:Humans; D008297:Male; D008661:Metabolism, Inborn Errors / Q000201:enzymology / Q000652:urine; D012978:Sodium Oxybate / Q000652:urine; D050644:Succinate-Semialdehyde Dehydrogenase; D020888:Vigabatrin
D000614:Aminocaproates; D000927:Anticonvulsants; D012978:Sodium Oxybate; D000445:Aldehyde Oxidoreductases; C493643:ALDH5A1 protein, human; D050644:Succinate-Semialdehyde Dehydrogenase; D020888:Vigabatrin